Your browser doesn't support javascript.
loading
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill, Roisin E; Miller, Austin; Soslow, Robert A; Lankes, Heather A; DeLair, Deborah; Segura, Sheila; Chavan, Shweta; Zamarin, Dmitriy; DeBernardo, Robert; Moore, Kathleen; Moroney, John; Shahin, Mark; Thaker, Premal H; Wahner-Hendrickson, Andrea E; Aghajanian, Carol.
Affiliation
  • O'Cearbhaill RE; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: ocearbhr@mskcc.org.
  • Miller A; Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: millera@nrgoncology.org.
  • Soslow RA; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: soslowr@mskcc.org.
  • Lankes HA; NRG Oncology, Operations Center-Philadelphia East, Philadelphia, PA, United States of America; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America. Electronic address: lankesh@nrgoncology.o
  • DeLair D; Northwell Health, Greenvale, New York, NY, United States of America. Electronic address: ddelair@northwell.edu.
  • Segura S; Indiana University School of Medicine, Indianapolis, IN, United States of America. Electronic address: ssegura@iu.edu.
  • Chavan S; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: schavan@repertoire.com.
  • Zamarin D; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: zamarind@mskcc.org.
  • DeBernardo R; Case Western University, Cleveland, OH, United States of America. Electronic address: DEBERNR@ccf.org.
  • Moore K; University of Oklahoma, Oklahoma City, OK, United States of America. Electronic address: Kathleen-Moore@ouhsc.edu.
  • Moroney J; University of Chicago, Chicago, IL, United States of America. Electronic address: jwmoroney@bsd.uchicago.edu.
  • Shahin M; Abington Memorial Hospital, Willow Grove, PA, United States of America. Electronic address: Mark.Shahin@jefferson.edu.
  • Thaker PH; Washington University, St. Louis, MO, United States of America. Electronic address: thakerp@wudosis.wustl.edu.
  • Wahner-Hendrickson AE; Mayo Clinic, Rochester, MN, United States of America. Electronic address: WahnerHendrickson.Andrea@mayo.edu.
  • Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: aghajanc@mskcc.org.
Gynecol Oncol ; 176: 16-24, 2023 09.
Article in En | MEDLINE | ID: mdl-37418832
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carcinoma, Endometrioid / Adenocarcinoma, Clear Cell Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carcinoma, Endometrioid / Adenocarcinoma, Clear Cell Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article